221 related articles for article (PubMed ID: 24465715)
1. Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer.
Ongkeko WM; Burton D; Kiang A; Abhold E; Kuo SZ; Rahimy E; Yang M; Hoffman RM; Wang-Rodriguez J; Deftos LJ
PLoS One; 2014; 9(1):e85803. PubMed ID: 24465715
[TBL] [Abstract][Full Text] [Related]
2. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
3. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
Park SI; McCauley LK
Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
8. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
9. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
12. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
[TBL] [Abstract][Full Text] [Related]
15. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.
Deng X; Tannehill-Gregg SH; Nadella MV; He G; Levine A; Cao Y; Rosol TJ
Clin Exp Metastasis; 2007; 24(2):107-19. PubMed ID: 17370040
[TBL] [Abstract][Full Text] [Related]
17. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells.
Shen X; Falzon M
Regul Pept; 2003 May; 113(1-3):17-29. PubMed ID: 12686457
[TBL] [Abstract][Full Text] [Related]
20. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]